Compare European CDMOs with EMA-compliant facilities across Germany, Switzerland, Ireland, and the broader EU. Filter by specialization, scale, and regulatory approvals.
1099 companies listed
Every country below has its own page with a ranked CDMO list, a country-zoomed facilities map, and the local regulatory picture. Counts are live manufacturing-site totals.
Austria
piCHEM is a privately owned Austrian company with over three decades of experience in the manufacturing of synthetic peptides and peptide-related molecules. Provides full GMP service for peptides used as active pharmaceutical ingredients (APIs), including process scale-up, process validation, analytical services, stability studies, and regulatory support. Also manufactures peptide precursors for radiopharmaceuticals/nuclear medicine. Offers aseptic fill & finish services in-house or through qualified partners. EU-GMP/cGMP certified, FDA registered for API manufacture.
Switzerland
PolyPeptide Group AG (SIX: PPGN) is a specialized global CDMO and market leader in peptide-based active pharmaceutical ingredient manufacturing. Supports pharmaceutical and biotech companies from pre-clinical through commercial scale. Operates six production sites worldwide with over 70 years of experience and 1,000+ GMP peptides manufactured. Strong exposure to GLP-1 therapies for metabolic diseases (diabetes, obesity). Currently expanding with a EUR 100M investment to double solid-phase peptide synthesis capacity at Malmo, Sweden. Also expanding in Belgium and Ambernath, India. Recently added oligonucleotide capabilities. Publicly traded on SIX Swiss Exchange.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.